Endocannabinoids & Pharmacology of Cannabis and Hemp

With the expansion of access to Cannabis products in many states without the oversight of a health care provider, patients are more often counseled by retail staff. The relevance of this instructional module is that it will provide the participant with the background on the medical history of Cannabis and the pharmacology of its chemical constituents to authoritatively discuss the product with patients.

The course delves into the botanical aspects of cannabis, highlighting the key differences between species and the importance of understanding chemotype for product efficacy. You will learn about the biosynthesis of cannabinoids and their relationship to endocannabinoids, with a special emphasis on delta-9-THC and CBD.

• You will gain a deeper understanding of the mechanisms of action of cannabinoids, including their interactions with CB1 and CB2 receptors and other relevant receptors.
• The course will examine the impact of the legal classification of hemp on the market, including the rise of unregulated products and the potential risks associated with synthetics.
• Furthermore, you will gain insights into various cannabis product types, their potency, bioavailability, and potential side effects.
• Finally, the course addresses the evolving field of cannabinoid research, including the development of novel therapies and the ongoing investigation of minor cannabinoids and terpenes.

This course is designed for healthcare providers who seek to enhance their knowledge and understanding of cannabis and its potential applications in patient care. You will be equipped with the necessary information to confidently discuss cannabis with patients and make informed recommendations based on scientific evidence and current regulations.